Total Funding
87
69
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
85620
Panosome is a biotech startup with a novel, proprietary platform to generate antibodies to small molecules, peptides, and proteins.
About the Company
Panosome is making the most challenging target classes such as carbohydrates, peptides and small molecules addressable to antibodies. Spun out of the German Cancer Research Center in 2020, Panosome is using the revolutionary VAST technology to address antibody targets in several indications, ranging from cancer to autoimmune diseases.
